Relationship between tumor necrosis factor‐alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annals medicus

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/07853890500317414PMID 16338762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of the blood ammonia in liver disease. Its diagnostic, prognostic, and therapeutic significance.

  2020cited by this paper
• Current Status of Hyperammonemic Syndromes

  2007cited by this paper
• Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.

  2004cited by this paper
• Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure.

  2004cited by this paper
• Systemic endotoxaemia following obstructive jaundice: the role of lactulose.

  2003cited by this paper
• Ammonia Neurotoxicity: Role of the Mitochondrial Permeability Transition

  2003cited by this paper
• Correlation between ammonia levels and the severity of hepatic encephalopathy.

  2003influential reference
• Hepatic encephalopathy—Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998

  2002cited by this paper
• Pathophysiology of Hepatic Encephalopathy: A New Look at Ammonia

  2002cited by this paper
• Hepatic encephalopathy

  2001cited by this paper
• Differential effects of cytokines and redox potential on glutamate uptake in rat cortical glial cultures.

  2001cited by this paper
• [Changes in plasma free amino acid concentrations in rats during sepsis].

  2001cited by this paper
• Effects of ammonia on glutamate transporter (GLAST) protein and mRNA in cultured rat cortical astrocytes.

  2000cited by this paper
• Partial pressure of ammonia versus ammonia in hepatic encephalopathy

  2000cited by this paper
• Development of a new, simple rat model of early alcohol‐induced liver injury based on sensitization of kupffer cells

  1999cited by this paper
• Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure.

  1997cited by this paper
• The glial glutamate transporter in hyperammonemia and hepatic encephalopathy: Relation to energy metabolism and glutamatergic neurotransmission

  1997cited by this paper
• Soluble TNF receptors as prognostic factors for mortality.

  1997cited by this paper
• Gut decontamination reduces bowel ischemia-induced lung injury in rats.

  1997cited by this paper
• Effects of Tumor Necrosis Factor-α and Interleukin-6 on Fluid-Phase Permeability and Ammonia Diffusion in CNS-Derived Endothelial Cells

  1996cited by this paper
• The Neurobiology of Hepatic Encephalopathy

  1996cited by this paper
• Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality.

  1996cited by this paper
• An alteration in the gamma-aminobutyric acid receptor system in experimentally induced septic shock in rats.

  1996cited by this paper
• Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells.

  1996cited by this paper
• Cytokine modulation of glial glutamate uptake: a possble involvement of nitric oxide

  1996cited by this paper
• Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure

  1996cited by this paper
• Synaptosomal glutamate transport in thioacetamide‐induced hepatic encephalopathy in the rat

  1995cited by this paper
• Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures.

  1994cited by this paper
• Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: an experimental study based on in vivo brain dialysis.

  1994cited by this paper
• Endotoxin and tumor necrosis factor-alpha in the pathogenesis of hepatic encephalopathy.

  1994cited by this paper
• Determination of Ammonia in Biological Fluids

  1994cited by this paper
• Effect of antitumour necrosis factor treatment on circulating tumour necrosis factor levels and mortality after surgery in jaundiced mice

  1993cited by this paper
• Interleukin‐1‐β and Tumor Necrosis Factor‐α Increase Peripheral‐Type Benzodiazepine Binding Sites in Cultured Polygonal Astrocytes

  1992cited by this paper
• Cerebral Ammonia Metabolism in Patients with Severe Liver Disease and Minimal Hepatic Encephalopathy

  1991cited by this paper
• Benzodiazepine compounds and hepatic encephalopathy.

  1991cited by this paper
• Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide.

  1991cited by this paper
• The pathogenesis of hepatic encephalopathy.

  1990cited by this paper
• Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.

  1990cited by this paper
• Tumor necrosis factor: immune endocrine interaction.

  1989cited by this paper
• Hepatic encephalopathy.

  1989cited by this paper
• When and How Should We Measure Plasma Ammonia?

  1988cited by this paper
• Gamma-Aminobutyric Acid (GABA) and Sepsis-Related Encephalopathy

  1988cited by this paper
• Acute in vivo effects of human recombinant tumor necrosis factor.

  1987cited by this paper
• Biochemistry and physiology of brain ammonia.

  1987cited by this paper
• Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6.

  1987cited by this paper
• Portal-systemic encephalopathy and hepatic coma.

  1986cited by this paper
• The Neurobiology of Hepatic Encephalopathy

  1984cited by this paper
• The Release and Neosynthesis of Glutamic Acid Are Increased in Experimental Models of Hepatic Encephalopathy

  1983cited by this paper
• The mechanism of hepatic coma

  1981cited by this paper
• The Hepatic Coma Syndromes and Lactulose

  1979cited by this paper
• The effect of acute hyperammoniemia on the electroencephalogram.

  1966cited by this paper
• A DOUBLE-BLIND STUDY OF THE EFFECT OF AMMONIUM INFUSION ON PSYCHOLOGICAL FUNCTIONING IN CIRRHOTIC PATIENTS

  1962cited by this paper
• Diseases of the Liver and Biliary System

  1955cited by this paper

• Neuroglia in hepatic encephalopathy.

  2025cites this paper
• Infection, inflammation and hepatic encephalopathy from a clinical perspective

  2024cites this paper
• Energy Metabolites and Indicative Significance of α-Ketoglutarate and α-Ketoglutaramate in Assessing the Progression of Chronic Hepatoencephalopathy

  2024cites this paper
• Bacterial DNA Translocation Is Associated With Overt Hepatic Encephalopathy and Mortality in Patients With Cirrhosis

  2024cites this paper
• Cut-off level of serum caspase-cleaved CK 18 (M30) for diagnosis of acute on chronic liver failure in chronic hepatitis C cirrhosis

  2024cites this paper
• Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis

  2023cites this paper
• Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats

  2023cites this paper
• The mechanistic and prognostic implications of heart rate variability analysis in patients with cirrhosis

  2022cites this paper
• Long Noncoding RNAs Regulate Hyperammonemia-Induced Neuronal Damage in Hepatic Encephalopathy

  2022cites this paper
• Correlation between Ascites and Total Lymphocyte Count with Occurrence of Hepatic Encephalopathy in Liver Cirrhosis Patients Hubungan Asites dan Total Lymphocyte Count dengan Kejadian Hepatic Encephalopathy pada

  2021cites this paper
• Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases.

  2021cites this paper
• Rapid metabolic and bioenergetic adaptations of astrocytes under hyperammonemia – a novel perspective on hepatic encephalopathy

  2021cites this paper
• Diagnosis and Management of Hepatic Encephalopathy

  2021cites this paper
• The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis.

  2021cites this paper
• Pathophysiology of Hepatic Encephalopathy.

  2020cites this paper
• Astrocyte swelling in hepatic encephalopathy: molecular perspective of cytotoxic edema

  2020cites this paper
• Study of interleukin-6 and its role in hepatic encephalopathy in patients with liver cirrhosis

  2019cites this paper
• Raised serum Interleukin‐6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy

  2019cites this paper
• Fragile X mental retardation protein protects against tumour necrosis factor-mediated cell death and liver injury

  2019cites this paper
• Umbelliferone prevents oxidative stress, inflammation and hematological alterations, and modulates glutamate-nitric oxide-cGMP signaling in hyperammonemic rats.

  2018cites this paper
• Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease.

  2018cites this paper
• Alterations in Expression and Function of ABC Family Transporters at Blood-Brain Barrier under Liver Failure and Their Clinical Significances

  2018cites this paper
• Neurocritical Care Management of Hepatic Encephalopathy and Coma in Liver Failure

  2018cites this paper
• Hepatic Encephalopathy: Pathophysiology—Brain

  2018cites this paper
• Commiphora molmol Modulates Glutamate-Nitric Oxide-cGMP and Nrf2/ARE/HO-1 Pathways and Attenuates Oxidative Stress and Hematological Alterations in Hyperammonemic Rats

  2017cites this paper
• TNFα induced up-regulation of Na+,K+,2Cl− cotransporter NKCC1 in hepatic ammonia clearance and cerebral ammonia toxicity

  2017cites this paper
• Neurosurgical Procedures in Patients with Cirrhosis and Acute Liver Failure: Indications, Safety, and Feasibility of Intracranial Pressure Monitor Devices

  2017cites this paper
• Cytokines in Hepatic Injury

  2017cites this paper
• Pathogenesis of canine liver disease

  2017cites this paper
• Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy

  2017cites this paper
• Asymmetric Dimethylarginine and Hepatic Encephalopathy: Cause, Effect or Association?

  2016cites this paper
• Characterization of the MMP/TIMP Imbalance and Collagen Production Induced by IL-1β or TNF-α Release from Human Hepatic Stellate Cells

  2016cites this paper
• Resveratrol Normalizes Hyperammonemia Induced ProInflammatory and Pro-Apoptotic Conditions in Rat Brain

  2016cites this paper
• Peripheral Influences of Methamphetamine Neurotoxicity

  2016cites this paper
• What we know: the inflammatory basis of hepatic encephalopathy

  2015cites this paper
• Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis.

  2015cites this paper
• Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.

  2015cites this paper
• Clinical science workshop: targeting the gut-liver-brain axis

  2015cites this paper
• Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology

  2015cites this paper
• Attenuation of Congenital Portosystemic Shunt Reduces Inflammation in Dogs

  2015cites this paper
• The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients

  2015cites this paper
• Detecting Minimal Hepatic Encephalopathy in an Endemic Country for Hepatitis B: The Role of Psychometrics and Serum IL-6

  2015cites this paper
• Hyperammonemia and Systemic Inflammatory Response Syndrome Predicts Presence of Hepatic Encephalopathy in Dogs with Congenital Portosystemic Shunts

  2014cites this paper
• Plasma cytokine concentrations in dogs with a congenital portosystemic shunt.

  2014cites this paper
• Hepatic encephalopathy in alcoholic cirrhosis.

  2014cites this paper
• Pathophysiology, diagnosis, and management of hepatic encephalopathy

  2014cites this paper
• Chronic Liver Disease, Cirrhosis and Complications: Part 2: Hepatic Encephalopathy and Other Systemic Effects

  2014cites this paper
• Efeitos da exposição à amônia em células astrogliais e neuronais : mecanismos protetores do resveratrol e do ácido lipoico

  2014cites this paper
• Role of Interleukin 6 as a Predictor of Hepatic encephalopathy in Critically Ill Cirrhotic Patients

  2013influential citation
• Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy

  2013cites this paper
• Role of Tumor Necrosis Factor Alpha , Ghrelin , Evoked Potentials in Hepatic Encephalopathy

  2013cites this paper
• Mellanby, R. J. (2014). Hyperammonemia and Systemic Inflammatory Response Syndrome Predicts Presence of Hepatic Encephalopathy in Dogs

  2013cites this paper
• Alterations of Blood-Brain Barrier and Associated Factors in Acute Liver Failure

  2013cites this paper
• Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis.

  2013cites this paper
• Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition

  2013cites this paper
• Inflammation and hepatic encephalopathy.

  2013cites this paper
• The metabolic and functional consequences of hyperammonaemia

  2012cites this paper
• Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy.

  2012cites this paper
• Role of cerebral endothelial cells in the astrocyte swelling and brain edema associated with acute hepatic encephalopathy.

  2012cites this paper
• Alterations of Blood Brain Barrier Function in Hyperammonemia: An Overview

  2011cites this paper
• Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms?

  2011cites this paper
• Pro‐inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy

  2011cites this paper
• Does interleukin-18 play a role in the pathogenesis of hepatic encephalopathy?

  2011cites this paper
• The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?

  2011cites this paper
• Association of TNF-α Genetic Polymorphisms with Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Han Chinese Population

  2011cites this paper
• p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts

  2011cites this paper
• Serum proinflammatory cytokines correlate with diffusion tensor imaging derived metrics and 1H-MR spectroscopy in patients with acute liver failure

  2010cites this paper
• Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4

  2010cites this paper
• Effect of Surgical Portosystemic Shunt on Prevalence of Minimal Hepatic Encephalopathy in Children With Extrahepatic Portal Venous Obstruction: Assessment by Magnetic Resonance Imaging and Psychometry

  2010cites this paper
• Role of Cytokines in the Pathophysiology of Acute-on-Chronic Liver Failure

  2009influential citation
• TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population.

  2009cites this paper
• Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy.

  2009cites this paper
• Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange.

  2009cites this paper
• IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy

  2009cites this paper
• Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma.

  2007cites this paper
• Cardiac rhythm abnormalities in cirrhosis

  2007cites this paper
• Relationship between circulating levels of tumour necrosis factor-alpha and Child-Pugh scores in liver cirrhosis.

  2007cites this paper
• Relationship between circulating levels of tumour necrosis factor‐α and Child–Pugh scores in liver cirrhosis

  2007cites this paper
• Tumor Necrosis Factor-α 308.2 Polymorphism Is Associated with Advanced Hepatic Fibrosis and Higher Risk for Hepatocellular Carcinoma

  2007cites this paper
• Pathogenesis of hepatic encephalopathy: the tumour necrosis factor‐α theory

  2007cites this paper
• Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients

  2007cites this paper
• Impaired 11 beta-hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: hypothesis or fact?

  2006cites this paper
• Impaired 11β‐hydroxysteroid dehydrogenase contributes to renal sodium avidity in cirrhosis: Hypothesis or fact?

  2006cites this paper
• Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease OF CLINICAL AND EXPERIMENTAL HEPATOLOGY

  year unknowncites this paper